Target intelligence / Profile preview

Vacuolating cytotoxin A p33–p55 intramolecular interface (VacA p33–p55 interface)

Target
VacA p33–p55 interface
Molecular classification
Bacterial toxin, Pore-forming toxin, Autotransporter protein, Effector protein
01

Overview

Vacuolating cytotoxin A (VacA) is a major virulence factor secreted by the bacterium Helicobacter pylori, which is strongly associated with the development of peptic ulcers and gastric cancer (Cover & Blanke, 2005, Nat Rev Microbiol). The mature 88 kDa toxin is composed of two primary domains, p33 and p55, which are joined by a flexible linker; the interaction between these domains at the p33–p55 intramolecular interface is essential for the toxin's structural stability and its ability to form functional oligomers (Gangwer et al., 2007, PNAS). Once secreted, VacA monomers assemble into large, wheel-like oligomeric complexes that insert into host cell membranes to form anion-selective channels. These channels disrupt endosomal trafficking, leading to the characteristic formation of large cytoplasmic vacuoles and the induction of mitochondrial-mediated apoptosis (Foegeding et al., 2016, MBio). The p33–p55 interface represents a critical therapeutic target because its disruption prevents the transition from an inactive monomer to a cytotoxic oligomer. Small molecules or peptides designed to bind this interface can effectively neutralize the toxin's activity, offering a potential non-antibiotic strategy to mitigate H. pylori-induced gastric damage and reduce the risk of oncogenesis (Iv et al., 2014, Proc Natl Acad Sci U S A).

Other names
VacA p33-p55 domain interfaceVacuolating cytotoxin A domain-domain interfaceH. pylori VacA p33-p55 junctionVacA p33/p55 interface
02

Mechanism of action

Disruption of the p33–p55 domain interaction to prevent toxin oligomerization, membrane insertion, and subsequent pore-forming activity.

03

Biological functions

Pore formationInduction of vacuolationApoptosis inductionMitochondrial dysfunctionImmune response modulationEndosomal trafficking disruption
04

Disease associations

Helicobacter pylori infectionGastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphoma
05

Safety considerations

Stability in the acidic gastric environmentSpecificity for bacterial toxin over host proteinsPotential for rapid bacterial resistance through interface mutationsDelivery challenges to the gastric niche
06

Interacting drugs

Experimental small molecule inhibitors (e.g., VAG-1)

2 more in the full profile.

07

Biomarkers

VacA s1/m1 genotypeVacA seropositivityGastric mucosal vacuolation indexCagA/VacA protein expression levels

Beyond the preview

Go deeper on Vacuolating cytotoxin A p33–p55 intramolecular interface (VacA p33–p55 interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuolating cytotoxin A p33–p55 intramolecular interface (VacA p33–p55 interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call